United Therapeutics Corporation
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $675.8M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $31.7M | 4.7% |
| Stock Repurchases | $323.6M | 47.9% |
| Working Capital | $207.1M | 30.6% |
| Net Cash Flow | $113.4M | 16.8% |